Otonomy, Inc. (OTIC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.4700 |
| Open | 0.4330 |
| Bid | 0.4495 x 2200 |
| Ask | 0.4601 x 800 |
| Day's Range | 0.4341 - 0.4700 |
| 52 Week Range | 0.2400 - 2.5900 |
| Volume | |
| Avg. Volume | 1,602,667 |
| Market Cap | 25.518M |
| Beta (5Y Monthly) | 1.53 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8100 |
| Earnings Date | Feb 09, 2022 - Feb 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.63 |
- Benzinga
Otonomy Shares Sink After Stopping Mid-Stage Tinnitus Study
Otonomy Inc (NASDAQ: OTIC) has announced that the OTO-313 Phase 2 trial in tinnitus demonstrated no clinically meaningful benefit versus placebo for primary and secondary endpoints across all time points. The 153-subject study did show a higher response rate than placebo in a prospectively defined patient subgroup with tinnitus duration of fewer than six months (population studied in Phase 1/2 trial). The overall results do not support further development of OTO-313. Also Read: Otonomy Hearing L
- GlobeNewswire
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue development of OTO-313 and implement other measures to extend its cash runway Clinical focus shifts to OTO-413 following positive Phase 2a results in April 2022; top-line results for evaluation of higher dosing still expected in fourth quarter of 2022 SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical
- Motley Fool
Otonomy (OTIC) Q2 2022 Earnings Call Transcript
Joining me on the call from Otonomy are Dr. David Weber, president and chief executive officer; and Paul Cayer, chief financial and business officer. Before I turn the call over to Dr. Weber, I would like to remind you that today's call will include forward-looking statements based on current expectations.
